We Are a team of

Life Science Entrepreneurs, Cardiologists, & Circulatory Support Experts

Procyrion is dedicated to improving the quality of life of millions of heart failure patients through the development of safe and innovative circulatory assist devices.  Procyrion is currently engaged in the development of the Aortix™ heart pump, designed to be the first non-surgical, minimally invasive, catheter deployed heart pump for long-term use. Aortix may improve the quality of life of millions of NYHA Stage III and early Stage IV heart failure patients.

Management

Benjamin A. Hertzog, PhD

President & CEO

Experienced start-up entrepreneur with a focus on medical devices, diagnostics and healthcare services. Managing Director of AlphaDev LLC; Vice President of BCM Technologies; McKinsey & Co. (Member of Pharmaceutical and Medical Products Practice); Ph.D. from Brown University’s Artificial Organs, Biomaterials, and Cellular Technology program.

Reynolds M. Delgado III, MD, FACC

Founder & Chief Medical Officer

Practicing cardiologist and leader in the field of heart failure. Medical Director, Mechanical Support Devices in Heart Failure, Texas Heart Institute; Advisory Board, Boston Scientific (LATITUDE HF monitoring system); Author on two NEJM articles that led to the FDA approval of the Heartmate II™ LVAD.

Jason Heuring, PhD

Chief Operating Officer

Experienced venture-backed founder of three start-ups; McKinsey & Co. consultant with CV OR and cath-lab focused engagements; Ph.D. from Oxford University in Sensors, Sensor Fusion, Control Systems, and Artificial Vision.

Will Clifton, MD

Director, Clinical Development

Medical entrepreneur with device development experience. MD: Baylor College of Medicine; B.S. Biomedical Engineering: University of Southern California; Howard Hughes Medical Research Fellow; Percutaneous Glucose Sensor Research and Development, Alfred Mann Institute for Biomedical Engineering, Los Angeles, CA.

Katherine Cox

Senior Director, Quality Assurance

Katherine is an experienced Quality Assurance professional, highly knowledgeable and skilled in Quality Engineering and in developing, implementing and maintaining Quality Management Systems compliant with 21 CFR 820, ISO 13485 and international regulations for successful 510k / CE Mark device registration and PMA approval.

Chris Durst, PhD

Senior Director, Product Development

Accomplished bioengineer and medical device entrepreneur with extensive experience in structural heart research; experience in world-class labs in both the US and Europe, developing enabling technologies for the treatment of valve disease; BS with highest honors from the Georgia Institute of Technology; PhD in Bioengineering from Rice University.

Ronnie Earles

Director, Product Development

An accomplished medical device designer with 24 years of experience in successfully commercializing new and novel products. Ronnie has experience with implant delivery systems, conceiving and designing new devices, developing production equipment, and contributing to FDA regulatory submissions.

Omar Benavides, PhD

Manager, Product Development

Scientist in the field of cardiovascular tissue engineering with experience in circulatory support devices and computer-aided design; Ph.D. Bioengineering, Rice University’s Pediatric Cardiovascular Bioengineering Lab at Texas Children’s Hospital; B.S. Biomedical Engineering, University of Texas at Austin.

Christian Landry

Manager, Product Development

A medical device engineer with over 25 years of experience in the medical device industry. Christian has worked for medical device startup companies successfully developing oral cancer screening devices and blood warmers for emergency first responders.

Tanner Songkakul

Engineer, Product Development

Electrical engineer specializing in medical device design. BS: Electrical Engineering, Rice University. Experienced hardware and software designer for medical devices including sensing hardware, detection algorithms, and user interface for the Saranas SmartSheath (Saranas, Houston, TX) and testing platform for the FastPace Subcutaneous Pacing Electrode (Rice University, Houston, TX).

Joseph Choi

Engineer, Clinical Development

Joseph graduated from Johns Hopkins University with a B.S. in biomedical engineering. During this time, Joseph worked on various translational research projects. His experience includes developing human-transplantable xenograft tissue and corneal adhesives as well as high throughput, lab-on-a-chip prototypes. Joseph received his MHS at Johns Hopkins Bloomberg School of Public Health in Immunobiology.

James Toll

Manager, Operations

A serial entrepreneur with extensive experience in the securities industry. Founded an investment advisory company, developed a family of smart beta alternative indexing products, and provided option education services. Previously Director of OTC Trading at Mercury Trading, a member of the Chicago Board Options Exchange, and a member of the CBOE's Product Development Committee.

Board of Directors

Gerhard “Gary” F. Burbach

Mr. Burbach, an accomplished medical device executive, joined Procyrion’s Board as an Independent Director in February 2016. From January 2006 to September 2014, Mr. Burbach served as president, chief executive officer, and director of Thoratec Corporation (NASDAQ: THOR).

Leo Linbeck, III

Leo Linbeck is the Chairman of AlphaDev Management Partners and President and CEO of Aquinas Companies, LLC, the sponsor of AlphaDev, Procyrion's seed investor. The Aquinas Companies, founded more than 70 years ago, have experienced exceptional growth over the last decade to achieve revenues now exceeding $600 million annually.

Carter Meyer

Carter Meyer is the Chief Executive Officer of Scientific Health Development (SHD) since its formation in February 2006, and is a General Partner of SHD II and SHD III. Prior to joining SHD, he was an attorney in private practice for over 12 years, most recently with the Dallas office of the Vinson & Elkins L.L.P.

Steve Oldham

Steve Oldham is the Vice President, Treasurer and Investor Relations of McDermott. He has 19 years of experience that includes responsibility for investor communications, capital structure and corporate liquidity management, bank and rating agency relationships, investment analysis, and foreign exchange risk mitigation.

Scientific Advisory Board

Keith Aaronson, MD

Professor, Department of Internal Medicine, University of Michigan; Medical Director, Heart Failure Program; Specialty: Cardiology, Cardiovascular Medicine; Clinical Interests: Heart failure and heart transplantation;

Emma Birks, MBBS, PhD, BSc, FRCP

Dr. Birks began her work in Ventricular Assist Devices in 1996 when she accepted a research position with the VAD program at the Royal Brompton and Harefield Hospital in London.

Manesh Patel, MD

Manesh R. Patel, MD, Chief of the Division of Cardiology for Duke's Department of Medicine, is an associate professor of medicine, a member of the Duke Clinical Research Institute, and director of Interventional Cardiology and Cardiac Catheterization Labs across the Duke University Health System.

Joseph Rogers, MD

Senior Vice Chair in the Duke Department of Medicine. In addition, he has been named Associate Chief Medical Officer of the Private Diagnostic Clinic (PDC), where he will oversee the PDC clinical growth over the next five years.

Hani Sabbah, PhD

Dr. Hani N. Sabbah is a tenured Professor of Medicine at Wayne State University in Detroit and the Director of Cardiovascular Research at the Henry Ford Health System in Detroit.